Last updated: February 19, 2026
What are the leading suppliers of bulk silver sulfadiazine API?
Silver sulfadiazine API is primarily used in topical antimicrobial formulations, especially burns treatment. The manufacturing and sourcing landscape includes several key regions and companies.
Major manufacturing regions
| Region |
Companies and Countries |
Details |
| China |
Zhejiang Hisun Pharmaceutical Co., Ltd.; Zhejiang, China |
Large-scale production, competitive pricing, regulated by NMPA |
| India |
Jubilant Life Sciences; Sun Pharma; Biocon |
Focused on generic APIs, GMP-compliant manufacturing sites |
| Europe |
Synthesis with facilities in Germany, Italy |
Mostly for high-quality, regulatory-compliant supply |
| United States |
Privately held companies; smaller scale production |
Limited domestic production, relies on imports |
Key suppliers of bulk silver sulfadiazine API
| Company Name |
Location |
Certification |
Production Capacity |
Notes |
| Zhejiang Hisun Pharmaceutical |
Zhejiang, China |
cGMP, ISO 9001 |
50+ tons/year |
Major supplier for global demand |
| Jubilant Life Sciences |
Uttar Pradesh, India |
cGMP, ISO 9001 |
20+ tons/year |
Tier-one supplier for global generics |
| Piramal Pharma Solutions |
Maharashtra, India |
cGMP, ISO 9001 |
10+ tons/year |
Focused on quality, small batch production |
| Synthesis (Europe) |
Europe (Germany, Italy) |
EUGMP, ISO 9001 |
5+ tons/year |
Usually for high-value markets |
Supply chain considerations
- Regulatory compliance: Manufacturers with certifications like cGMP, ISO 9001 are preferred.
- Pricing: Chinese suppliers generally offer lower costs because of scale.
- Quality verification: European suppliers tend to meet stringent testing standards, suitable for highly regulated markets.
- Availability: Manufacturing capacity fluctuates based on regional demand and global supply chain disruptions.
Sourcing trends and challenges
- Quality control: Differentiates suppliers. Key for contracts requiring regulatory approval.
- Price competition: Chinese suppliers capture most of the market share due to cost advantages.
- Supply constraints: Disrupted by geopolitical issues, pandemic-related manufacturing delays, and raw material shortages.
- Regulatory barriers: Suppliers must adhere to regional Good Manufacturing Practice (GMP) standards to serve developed markets like the US and EU.
Summary of key APIs sources
| Supplier Region |
Production Focus |
Certification |
Market Share Dominance |
Known for |
| China |
Cost-effective bulk API |
cGMP, ISO |
Large |
Cost and quantity |
| India |
Quality, volume flexibility |
cGMP, ISO |
Moderate |
Cost and quality balance |
| Europe |
High compliance, quality |
EUGMP, ISO |
Low to moderate |
Quality, regulatory focus |
| US |
Niche, high compliance |
cGMP |
Small |
High-value, regulatory |
Final notes
Decisions on API sourcing involve balancing price, quality, regulatory compliance, and supply reliability. Chinese and Indian suppliers dominate volume, while European and US suppliers focus on quality and regulatory standards.
Key Takeaways
- China remains the largest supplier of bulk silver sulfadiazine API, offering competitive pricing and high volume.
- Indian manufacturers balance price and quality, with GMP compliance suited for global markets.
- European and US suppliers focus on quality, meeting stringent regulatory standards but on smaller scales.
- Supply chain disruptions impact availability, emphasizing the importance of supplier diversification.
- Regulatory certification significantly influences supplier choice in developed markets.
FAQs
1. What certifications should I verify when sourcing silver sulfadiazine API?
Look for cGMP, ISO 9001, or EUGMP certificates. These assure quality management and regulatory compliance.
2. How does pricing differ between regions?
Chinese suppliers offer the lowest costs due to economies of scale. Indian suppliers offer a middle ground with a focus on balancing cost and quality.
3. Are there potential import restrictions for Chinese APIs in US and EU markets?
Yes. US FDA and EU EMA regulate imported APIs. Suppliers must meet regional standards and submit proper documentation.
4. How reliable are regional supply chains?
Chinese suppliers have high capacity but may face geopolitical or logistical issues. Indian suppliers have similar risks but often maintain diversified manufacturing sites.
5. Can high-quality European suppliers meet global demand?
They can, but their capacity is limited compared to Asian suppliers. They primarily serve markets requiring strict regulatory adherence.
References
[1] Food and Drug Administration (FDA). (2022). API Manufacturer Approval Process. FDA.gov.
[2] European Medicines Agency (EMA). (2022). Guidelines on Good Manufacturing Practices. EMA.europa.eu.
[3] Worldwide Market for Active Pharmaceutical Ingredients (API). (2023). IQVIA.